These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 417415)

  • 1. Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys.
    Addonizio VP; Strauss JF; Macarak EJ; Colman RW; Edmunds H
    Surgery; 1978 Jun; 83(6):619-25. PubMed ID: 417415
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
    Addonizio VP; Strauss JF; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of monkey (M. mulatta) platelets compared to platelets of pig, sheep, and man.
    Addonizio VP; Edmunds LH; Colman RW
    J Lab Clin Med; 1978 Jun; 91(6):989-97. PubMed ID: 418128
    [No Abstract]   [Full Text] [Related]  

  • 4. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation and white thrombus formation by prostaglandin analogue ONO-747.
    Ojima M; Fujita K
    Adv Prostaglandin Thromboxane Res; 1976; 2():781-5. PubMed ID: 983877
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass.
    Addonizio VP; Macarak EJ; Niewiarowski S; Colman RW; Edmunds LH
    Circ Res; 1979 Mar; 44(3):350-7. PubMed ID: 761317
    [No Abstract]   [Full Text] [Related]  

  • 11. Preservation of platelets during extracorporeal circulation with prostaglandin E1.
    Addonizio VP; Macarak EJ; Niewiarowski S; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1977; 23():639-45. PubMed ID: 910394
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet-anti-aggregating and hemodynamic effects of adenosine and prostaglandin E1.
    Masters TN; Born GV; Robicsek F
    Thorac Cardiovasc Surg; 1982 Feb; 30(1):14-20. PubMed ID: 6179225
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of Soviet-made prostaglandin E1 on the aggregation of thrombocytes and erythrocytes].
    Lakin KM; Makarov VA; Ovnatanova MS; Azhgikhin IS
    Farmakol Toksikol; 1976; 39(4):436-40. PubMed ID: 1027569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous adenosine diphosphate on the number of circulating platelets in experimental animals: inhibition by prostaglandin E1, dipyridamole, SH-869 and VK-774.
    Holmes IB; Smith GM; Freuler F
    Thromb Haemost; 1977 Feb; 37(1):36-46. PubMed ID: 402707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
    Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.